Disclosed are compounds which are inhibitors of metalloproteases and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the compounds have a structure according to the following Formula (I): ##STR1##

where R1, R2, R3, n, A, E, X, G, G, M and Z have the meanings described in the specification and the claims, as well as optical isomers, diastereomers and enantiomers of Formula I, and pharmaceutically-acceptable salts, biohydrolyzable amides, esters, and imides thereof. Also described are pharmaceutical compositions comprising these compounds, and methods of treating metalloprotease-related maladies using the compounds or the pharmaceutical compositions.

 
Web www.patentalert.com

< High fidelity thermostable ligase and uses thereof

< Methods for treating macular degeneration with topiramate

> Pyrazine based inhibitors of glycogen synthase kinase 3

> Substituted amino methyl factor Xa inhibitors

~ 00210